Table 3

 White matter perfusion results (ml/min/100 ml) based on T1 segmentation in all subjects

SubjectnWM perfusion ml/min/100 ml (SD)MS−control difference*p*Median T1 lesion volume (range), mlMedian PD lesion volume (range), ml
*Difference adjusted for gender; p value is for this difference compared with controls.
Controls3424.2 (4.2)00
All MS groups6027.2 (5.3)2.890.0071.2 (0–15.3)5.7 (0.1–52.6)
Relapsing remitting2127.4 (4.7)3.120.030.7 (0–8.3)4.6 (0.1–52.6)
    No treatment1028.1 (5.3)3.720.040.6 (0–7.9)5.5 (0.3–52.6)
    On β-interferon1126.7 (4.1)2.560.140.7 (0–8.3)3.0 (0.1–22.4)
Secondary progressive1428.3 (5.7)3.720.022.8 (0.2–15.3)10.3 (1.3–36.8)
Primary progressive1225.8 (5.0)1.620.331.7 (0–10.4)10.1 (1.3–44.9)
Benign1327.1 (6.2)2.830.082.0 (0.3–9.8)5.4 (0.9–19.4)